🧬
Gen Terapisi Sektörü Hisseleri
Gen Terapisi Sektörü altında 55 Hisse Senedi
Gen Terapisi sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
55
Toplam Hisse
$29.1B
Toplam Piyasa Değeri
Gen Terapisi Sektörü Hisseleri
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | $4.31B | $149.00 | 0.88% |
| ACLX | Arcellx, Inc. | $3.87B | $69.75 | 0.52% |
| LEGN | Legend Biotech Corporation | $3.14B | $34.22 | 1.47% |
| DYN | Dyne Therapeutics, Inc. | $1.92B | $13.50 | 0.07% |
| SRPT | Sarepta Therapeutics, Inc. | $1.77B | $18.16 | 0.22% |
| BEAM | Beam Therapeutics Inc. | $1.65B | $16.31 | 0.31% |
| STOK | Stoke Therapeutics, Inc. | $1.07B | $19.59 | 0.86% |
| IOVA | Iovance Biotherapeutics, Inc. | $792.46M | $2.19 | 1.79% |
| SANA | Sana Biotechnology, Inc. | $674.49M | $2.84 | 7.19% |
| TSHA | Taysha Gene Therapies, Inc. | $674.37M | $2.84 | 2.74% |
| MGTX | MeiraGTx Holdings plc | $587.03M | $7.30 | 0.00% |
| PRME | Prime Medicine, Inc. | $555.97M | $3.12 | 3.70% |
| RGNX | REGENXBIO Inc. | $460.69M | $9.12 | 2.13% |
| REPL | Replimune Group, Inc. | $460.53M | $5.90 | 9.26% |
| ARCT | Arcturus Therapeutics Holdings Inc. | $453.48M | $16.70 | 1.82% |
| SLDB | Solid Biosciences Inc. | $422.83M | $5.43 | 0.91% |
| BNTC | Benitec Biopharma Inc. | $361.60M | $13.78 | 4.04% |
| ABEO | Abeona Therapeutics Inc. | $351.25M | $6.85 | 0.29% |
| RCKT | Rocket Pharmaceuticals, Inc. | $349.61M | $3.24 | 1.22% |
| FULC | Fulcrum Therapeutics, Inc. | $346.73M | $6.41 | 1.08% |
| DSGN | Design Therapeutics, Inc. | $326.31M | $5.73 | 3.62% |
| LRMR | Larimar Therapeutics, Inc. | $317.54M | $3.71 | 2.49% |
| FDMT | 4D Molecular Therapeutics, Inc. | $286.73M | $6.14 | 0.32% |
| NGNE | Neurogene Inc. | $280.30M | $19.64 | 6.28% |
| TSVT | 2seventy bio, Inc. | $266.14M | $5.00 | 0.00% |
| RNAC | Cartesian Therapeutics, Inc. | $255.86M | $9.84 | 2.09% |
| ALLO | Allogene Therapeutics, Inc. | $248.49M | $1.12 | 0.89% |
| EDIT | Editas Medicine, Inc. | $222.10M | $2.47 | 3.89% |
| LYEL | Lyell Immunopharma, Inc. | $219.20M | $11.41 | 2.98% |
| CRGX | CARGO Therapeutics, Inc. Common Stock | $216.19M | $4.47 | 0.00% |
| KRRO | Korro Bio, Inc. | $208.52M | $22.20 | 3.79% |
| TRDA | Entrada Therapeutics, Inc. | $204.64M | $5.38 | 1.65% |
| TIL | Instil Bio, Inc. | $197.26M | $29.22 | 8.22% |
| TNYA | Tenaya Therapeutics, Inc. | $176.01M | $1.08 | 4.42% |
| SGMO | Sangamo Therapeutics, Inc. | $162.74M | $0.54 | 3.73% |
| LXEO | Lexeo Therapeutics, Inc. Common Stock | $159.01M | $4.79 | 0.00% |
| KYTX | Kyverna Therapeutics, Inc. | $155.25M | $3.59 | 3.23% |
| NKTX | Nkarta, Inc. | $149.15M | $2.10 | 0.94% |
| CABA | Cabaletta Bio, Inc. | $132.62M | $1.45 | 0.00% |
| FATE | Fate Therapeutics, Inc. | $118.79M | $1.03 | 0.96% |
| ATRA | Atara Biotherapeutics, Inc. | $86.66M | $12.34 | 2.41% |
| ARTV | Artiva Biotherapeutics, Inc. | $75.28M | $3.09 | 1.90% |
| ADVM | Adverum Biotechnologies, Inc. | $63.79M | $3.04 | 1.30% |
| INKT | MiNK Therapeutics, Inc. | $62.66M | $13.86 | 2.67% |
| ACET | Adicet Bio, Inc. | $61.14M | $0.73 | 2.00% |
| DTIL | Precision BioSciences, Inc. | $58.94M | $5.00 | 2.04% |
| BLUE | bluebird bio, Inc. | $48.67M | $4.97 | 0.00% |
| GBIO | Generation Bio Co. | $40.28M | $5.98 | 0.33% |
| PEPG | PepGen Inc. | $39.36M | $1.20 | 3.45% |
| PASG | Passage Bio, Inc. | $22.60M | $7.11 | 0.28% |
| CARM | Carisma Therapeutics, Inc. | $18.39M | $0.44 | 104.65% |
| PHIO | Phio Pharmaceuticals Corp. | $10.17M | $2.12 | 7.61% |
| ERNA | Eterna Therapeutics Inc. | $9.86M | $1.34 | 1.10% |
| GNPX | Genprex, Inc. | $5.29M | $0.16 | 3.54% |
| TCRT | Alaunos Therapeutics, Inc. | $4.51M | $2.28 | 7.04% |